tiprankstipranks
Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX
Australian Market
ATX
Amplia Therapeutics
RESEARCH TOOLSreports
Want to see AU:ATX full AI Analyst Report?

Amplia Therapeutics (ATX) Stock News & Sentiment

24 Followers
Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
Premium
Company Announcements
Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
11d ago
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
Premium
Company Announcements
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
11d ago
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
Premium
Company Announcements
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
15d ago
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
Premium
Company Announcements
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
25d ago
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
Premium
Company Announcements
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
1M ago
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
Premium
Company Announcements
Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens
2M ago
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
Premium
Company Announcements
Amplia posts unprecedented complete responses and survival gain in pancreatic cancer trial
2M ago
More AU:ATX News >

ATX News on the Web

Health Check: Invion eyes new angle on Opthea trial flop
StockHead
Bullish
Amplia Issues New Shares Under Executive Equity Plan, Affirms Regulatory Compliance
TipRanks News
Bullish
Amplia and ANZGOG launch narmafotinib ovarian cancer trial targeting high‑need patients
TipRanks News
Bullish
Health Check: Resmed goes out on a limb with its ‘restless leg’ purchase
StockHead
Bearish
Amplia advances narmafotinib program with strong pancreatic cancer data and Phase 3 readiness steps
TipRanks News
Neutral
Health Check: Cochlear#8217;s grim earnings update is hard for investors to hear
StockHead
Bullish
Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities
TipRanks News
Bullish
Biocurious: Battered local biotech valuations provide golden opportunities
StockHead
Neutral

News Score - Last 7 Days

Very Positive
AU:ATX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:ATX’s Media Buzz Sentiment?
1 articles about AU:ATX were published this week. In an average week, 1.25 articles are published.
    What is AU:ATX’s weekly average amount of articles?
    In an average week, 1.25 articles about AU:ATX are published.
      What is AU:ATX’s News Sentiment?
      100% of articles about AU:ATX were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        JUNSJupiter Neurosciences, Inc.
        Showing the stocks with the most bullish news sentiment over the past week